Premium
Centralisation of services for the management of ovarian cancer: arguments for
Author(s) -
Olaitan A,
McCormack M
Publication year - 2007
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2007.01460.x
Subject(s) - centralisation , ovarian cancer , medicine , cancer , service (business) , presentation (obstetrics) , quality of life (healthcare) , gynecology , political science , business , nursing , surgery , marketing , law
The recommendation in 1999, by the National Health Service Executive (NHSE) that the management of gynaecological cancer be centralised, led to a reorganisation of services for women with gynaecological malignancies. Debate has continued about the feasibility and benefits of ovarian cancer centralisation particularly because its insidious presentation can make it difficult to identify women with ovarian cancer before surgery. Despite this, there is clear evidence that centralisation is advantageous to women in terms of quality of life, morbidity and survival.